PT332 James Lanthier Patentability, Capitalism, and The Next Generation of Psychedelics

Published: June 28, 2022, 2:20 p.m.

b'

In this episode of the podcast, Joe interviews James Lanthier, the CEO of Mindset Pharma; a biotechnology company discovering and developing new (and hopefully safer, more predictable, and more palatable) psychedelic compounds.

www.psychedelicstoday.com

'